SCM

Silverarc Capital Management Portfolio holdings

AUM $489M
This Quarter Return
+29.68%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$236M
AUM Growth
+$236M
Cap. Flow
+$10.9M
Cap. Flow %
4.62%
Top 10 Hldgs %
41.83%
Holding
92
New
24
Increased
26
Reduced
17
Closed
14

Top Buys

1
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
$7.67M
2
PRTA icon
Prothena Corp
PRTA
$6.67M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
$6.51M
4
VRAY
ViewRay, Inc.
VRAY
$5.79M
5
PLRX icon
Pliant Therapeutics
PLRX
$4.38M

Top Sells

1
ITCI
Intra-Cellular Therapies Inc.
ITCI
$8.27M
2
APLS icon
Apellis Pharmaceuticals
APLS
$5.87M
3
BIIB icon
Biogen
BIIB
$4.25M
4
SGEN
Seagen Inc. Common Stock
SGEN
$4.13M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$3.84M

Sector Composition

1 Healthcare 96.41%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VERU icon
76
Veru
VERU
$48.5M
– –
0
– –
SPRY icon
77
ARS Pharmaceuticals
SPRY
$1.08B
– –
-209,108
Closed -$887K
SNDX icon
78
Syndax Pharmaceuticals
SNDX
$1.39B
– –
-107,852
Closed -$2.08M
RLMD icon
79
Relmada Therapeutics
RLMD
$48.8M
– –
0
– –
PYPD icon
80
PolyPid
PYPD
$54.4M
– –
-161,572
Closed -$750K
MREO
81
Mereo BioPharma
MREO
$275M
– –
-156,195
Closed -$175K
DAWN icon
82
Day One Biopharmaceuticals
DAWN
$766M
– –
-105,476
Closed -$1.89M
CLNN icon
83
Clene
CLNN
$55.8M
– –
0
– –
CGEN icon
84
Compugen
CGEN
$133M
– –
-104,150
Closed -$193K
BIIB icon
85
Biogen
BIIB
$20.8B
– –
-20,825
Closed -$4.25M
AVXL icon
86
Anavex Life Sciences
AVXL
$817M
– –
0
– –
APLS icon
87
Apellis Pharmaceuticals
APLS
$3.51B
– –
-129,795
Closed -$5.87M
ALGS icon
88
Aligos Therapeutics
ALGS
$75.1M
– –
-58,392
Closed -$71K
FMTX
89
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
– –
-94,386
Closed -$650K
CFRX
90
DELISTED
ContraFect Corporation
CFRX
– –
0
– –
BHVN
91
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-26,374
Closed -$3.84M
QQQ icon
92
Invesco QQQ Trust
QQQ
$364B
– –
0
– –
1 2 3
4